• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylbutylamines

4-Ethoxy-3-fluoro-N-(2-hydroxy-2-methyl-4-phenylbutyl)benzene-1-sulfonamide: A Comprehensive Overview

The compound 4-Ethoxy-3-fluoro-N-(2-hydroxy-2-methyl-4-phenylbutyl)benzene-1-sulfonamide (CAS No. 1286704-01-5) is a complex organic molecule with a diverse range of potential applications in the pharmaceutical and chemical industries. This compound is characterized by its unique structure, which includes a benzene ring substituted with an ethoxy group, a fluoro group, and a sulfonamide moiety. The sulfonamide group is further substituted with a hydroxyl and methyl group, along with a phenyl substituent, making it a highly functionalized molecule.

Recent studies have highlighted the importance of sulfonamides in drug design due to their ability to act as bioisosteres of carboxylic acids and other functional groups. The sulfonamide moiety in this compound has been shown to enhance the stability and bioavailability of drugs, making it a valuable component in the development of new therapeutic agents. Additionally, the presence of the ethoxy and fluoro groups introduces electronic effects that can modulate the compound's activity and selectivity.

The benzene ring in this molecule serves as a versatile platform for further functionalization, allowing for the attachment of various substituents that can influence its pharmacokinetic properties. For instance, the ethoxy group can act as a lipophilic substituent, enhancing the compound's solubility in organic solvents. Meanwhile, the fluoro group introduces electron-withdrawing effects, which can alter the molecule's reactivity and binding affinity to biological targets.

One of the most intriguing aspects of this compound is its potential as a lead molecule in drug discovery. Researchers have explored its ability to inhibit various enzymes and receptors, which could make it a candidate for treating diseases such as cancer, inflammation, and neurodegenerative disorders. For example, recent studies have demonstrated that sulfonamides like this one can inhibit kinases involved in cell signaling pathways, potentially offering new avenues for anti-cancer therapies.

The sulfonamide moiety also plays a critical role in determining the compound's pharmacokinetic profile. Sulfonamides are known to exhibit good oral bioavailability and low toxicity, making them ideal candidates for systemic drug delivery. Furthermore, the presence of hydroxyl groups in the molecule can enhance its solubility in aqueous media, which is essential for its absorption and distribution within the body.

In terms of synthesis, this compound can be prepared through a multi-step process involving nucleophilic aromatic substitution and coupling reactions. The synthesis begins with the preparation of the benzene ring substituted with ethoxy and fluoro groups. This intermediate is then subjected to nucleophilic aromatic substitution using an appropriate amine derivative to introduce the sulfonamide group. Finally, further functionalization steps are employed to introduce the hydroxyl and methyl groups on the butyl chain.

Recent advancements in green chemistry have also led to more sustainable methods for synthesizing such compounds. For instance, researchers have explored the use of microwave-assisted synthesis and catalytic systems to improve reaction yields while reducing environmental impact. These methods are particularly useful for preparing complex molecules like 4-Ethoxy-3-fluoro-N-(2-hydroxy-2-methyl-4-phenylbutyl)benzene-1-sulfonamide, where multiple functional groups need to be introduced in precise positions.

The sulfonamide moiety has also been implicated in enhancing drug-drug interactions (DDIs), which is an important consideration during preclinical development. Researchers have found that certain sulfonamides can inhibit cytochrome P450 enzymes responsible for drug metabolism, potentially leading to adverse interactions with other medications. However, studies on this specific compound suggest that it has minimal inhibitory effects on these enzymes under physiological conditions.

In addition to its therapeutic potential, this compound has also found applications in materials science due to its unique electronic properties. The combination of electron-donating (ethoxy) and electron-withdrawing (fluoro) groups on the benzene ring creates an imbalance in electron density that can be exploited for applications such as nonlinear optics or organic electronics.

Looking ahead, ongoing research aims to further optimize this compound's properties through structural modifications. For example, researchers are exploring variations where the ethoxy group is replaced with other alkoxy substituents or where additional functional groups are introduced on the butyl chain. These modifications could enhance its bioactivity or enable new modes of action against disease targets.

In conclusion, 4-Ethoxy-3-fluoro-N-(2-hydroxy-2-methyl-4-phenylbutyl)benzene-1-sulfonamide (CAS No. 1286704-01-5) represents a promising lead molecule with diverse applications across multiple fields. Its unique structure offers opportunities for both therapeutic development and materials science innovation while ongoing research continues to uncover new insights into its properties and potential uses.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)